Risk of third and fourth tumors in patients with head and neck cancer.
about
Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary GuidelinesHigh RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.Second, third, and fourth head and neck tumors. A progressive decrease in survival.
P2860
Risk of third and fourth tumors in patients with head and neck cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Risk of third and fourth tumors in patients with head and neck cancer.
@en
Risk of third and fourth tumors in patients with head and neck cancer.
@nl
type
label
Risk of third and fourth tumors in patients with head and neck cancer.
@en
Risk of third and fourth tumors in patients with head and neck cancer.
@nl
prefLabel
Risk of third and fourth tumors in patients with head and neck cancer.
@en
Risk of third and fourth tumors in patients with head and neck cancer.
@nl
P2093
P2860
P356
P1433
P1476
Risk of third and fourth tumors in patients with head and neck cancer.
@en
P2093
Jacinto García
Montserrat López
Vicenç Martínez
Xavier León
P2860
P304
P356
10.1002/HED.21348
P50
P577
2010-11-01T00:00:00Z